Congressional disclosure · IDXX
Jefferson Shreve
House · R-IN
profile →
IDEXX Laboratories, Inc.
IDXX · Healthcare · 35 filings in 24 months
ticker →
Jefferson Shreve sold $100K–250K of IDEXX Laboratories (IDXX)
Executed May 12 2025, disclosed Jun 22 2025, 41 days later. Jefferson Shreve sits on Appropriations.
Disclosed value
$175K
$100K–250K bracket
Executed
May 12 2025
the trade date, as filed
Disclosed
Jun 22 2025
41 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JSJefferson Shreve (R-IN) sits on Appropriations. In the past 24 months, Jefferson Shreve filed 4 disclosures under the STOCK Act (4 purchases, 4 sales, 1 filed past the 45-day window). Across 185 priced purchase filings, the average 21-session return was +4.7% from execution and +5.0% from disclosure (delay-adjusted; derived).
The name
IDXXHealthcare · IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy…
More Healthcare filings→ Congressional filings, newest first→ View the original filing at disclosures-clerk.house.gov→Other filings by Jefferson Shreve in IDXX
IDXXPURCHASE
IDEXX Laboratories, Inc.
$75K$50K–100K bracket
Exec Apr 7 2025
Filed May 8 2025 IDXXPURCHASE IDEXX Laboratories, Inc. $33K
$15K–50K bracket
Exec Mar 13 2025
Filed Apr 11 2025